CATHEPSIN-D IMMUNOSTAINING IN PARAFFIN-EMBEDDED BREAST-CANCER CELLS AND MACROPHAGES - CORRELATION WITH CYTOSOLIC ASSAY

被引:57
作者
ROGER, P
MONTCOURRIER, P
MAUDELONDE, T
BROUILLET, JP
PAGES, A
LAFFARGUE, F
ROCHEFORT, H
机构
[1] HOSP GUI CHAULIAC,DEPT PATHOL,MONTPELLIER,FRANCE
[2] HOSP ARNAUD VILLENEUVE,DEPT OBSTET & GYNECOL,MONTPELLIER,FRANCE
关键词
CATHEPSIN D; BREAST CANCER; PHAGOSOMES; IMMUNOHISTOCHEMISTRY; MACROPHAGES;
D O I
10.1016/0046-8177(94)90004-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
High cathepsin D (cath-D) concentration in breast cancer cytosol is associated with increased risk of metastasis. To specify the relative contribution of the different cells types responsible for cath-D level in cytosol, we validated semiquantitative cath-D immunoperoxidase staining on formalin-fixed, paraffin-embedded sections, using the M1G8 monoclonal antibody, one of the two antibodies of the cytosolic assay. Using computer-aided image analysis, cath-D level in cancer cells was estimated by integrating both staining intensity in each cell and proportion of stained cells. We confirmed on 41 primary breast cancers a higher expression of cath-D in cancer cells compared with peritumoral mammary glands. Cancer cell staining was mostly in lysosomes and for some invasive ductal carcinomas in large vesicles corresponding to phagosomes. Lymphocytes and fibroblasts were not or were only weakly stained. Macrophages also were stained for cath-D, generally on the periphery of the tumor area. The cytosolic cath-D level was correlated with cath-D expression in cancer cells (r = .76; P = 1 X 10(-4)) rather than with the number of macrophages in the tumor (r = .29; P = .09), as determined by use of the specific anti-CD68 antibody. There was a significant increase in the tissue cath-D level in tumors containing large vesicles compared with tumors without large vesicles. This approach provides a means to separately estimate the prognostic significance of cath-D expression in cancer cells and macrophages when evaluating risk of metastasis. HUM PATHOL 25:863-871. Copyright (C) 1994 by W.B. Saunders Company
引用
收藏
页码:863 / 871
页数:9
相关论文
共 40 条
[1]   LYMPHOCYTE INFILTRATES AS A PROGNOSTIC VARIABLE IN FEMALE BREAST-CANCER [J].
AALTOMAA, S ;
LIPPONEN, P ;
ESKELINEN, M ;
KOSMA, VM ;
MARIN, S ;
ALHAVA, E ;
SYRJANEN, K .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :859-864
[2]   THE PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR ANALYSIS IN PARAFFIN-EMBEDDED AND FROZEN-SECTIONS VERSUS THAT OF STEROID-BINDING ASSAYS [J].
ANDERSEN, J ;
THORPE, SM ;
KING, WJ ;
ROSE, C ;
CHRISTENSEN, I ;
RASMUSSEN, BB ;
POULSEN, HS .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) :442-449
[3]   THE EVALUATION OF ESTROGEN-RECEPTOR IN PRIMARY BREAST-CARCINOMA BY COMPUTER-ASSISTED IMAGE-ANALYSIS [J].
BACUS, S ;
FLOWERS, JL ;
PRESS, MF ;
BACUS, JW ;
MCCARTY, KS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (03) :233-239
[4]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[5]   CATHEPSIN D ASSAY IN PRIMARY BREAST-CANCER AND LYMPH-NODES - RELATIONSHIP WITH C-MYC, C-ERB-B-2 AND INT-2 ONCOGENE AMPLIFICATION AND NODE INVASIVENESS [J].
BROUILLET, JP ;
THEILLET, C ;
MAUDELONDE, T ;
DEFRENNE, A ;
SIMONYLAFONTAINE, J ;
SERTOUR, J ;
PUJOL, H ;
JEANTEUR, P ;
ROCHEFORT, H .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) :437-441
[6]   IMMUNORADIOMETRIC ASSAY OF PRO-CATHEPSIN-D IN BREAST-CANCER CYTOSOL - RELATIVE PROGNOSTIC VALUE VERSUS TOTAL CATHEPSIN-D [J].
BROUILLET, JP ;
SPYRATOS, F ;
HACENE, K ;
FAUQUE, J ;
FREISS, G ;
DUPONT, F ;
MAUDELONDE, T ;
ROCHEFORT, H .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) :1248-1251
[7]  
CHARPIN C, 1992, ANTICANCER RES, V12, P591
[8]   IMMUNOCYTOCHEMICAL DETERMINATION OF THE ESTROGEN-REGULATED PROTEINS MR 24,000, MR 52,000 AND DF3 BREAST-CANCER ASSOCIATED ANTIGEN - CLINICAL-VALUE IN ADVANCED BREAST-CANCER AND CORRELATION WITH ESTROGEN-RECEPTOR [J].
DAMSTRUP, L ;
ANDERSEN, J ;
KUFE, DW ;
HAYES, DF ;
POULSEN, HS .
ANNALS OF ONCOLOGY, 1992, 3 (01) :71-77
[9]  
DESOMBRE ER, 1986, CANCER RES, V46, P4256
[10]  
DOMAGALA W, 1992, AM J PATHOL, V141, P1003